Real-time, multiplexed SHERLOCK for in vitro diagnostics
Description
The SARS-CoV-2 pandemic has highlighted the need for simple, low-cost, and scalable diagnostics that can be widely deployed for rapid testing. CRISPR-based diagnostics have emerged as a promising technology, but the implementation in clinical labs
